CrossrefInfokarte
The CALLY Index for Unresectable or Recurrent Gastric Cancer Treated With Nivolumab: A Multicenter Retrospective Study
Journal of Gastric Cancer · 2026 · 26 (4) · 598
DOI: 10.5230/jgc.2026.26.e46 ↗Abstract
Kein Abstract verfügbar.
EUVIMED